09.04.2020
- US President Donald Trump’s relentless promotion of the 86-year-old generic drug hydroxychloroquine, used successfully to treat malaria, lupus and rheumatoid arthritis, as an...
30.03.2020
- Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, has agreed to collaborate with Translate Bio, a US clinical-stage messenger RNA (mRNA) therapeutics...
26.02.2020
- Together for Sustainability (TFS), a global, procurement-driven chemical industry initiative emphasizing sustainable supply chains, has further increased its impact by adding...
25.02.2020
- French drugmaker Sanofi plans to establish a new major active pharmaceutical ingredients company that it says would secure significant manufacturing and supply capacities that are...
19.02.2020
- Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, plans to work with the Biomedical Advanced Research and Development Authority (BARDA), part of the US...
13.02.2020
- Paul Hudson, new CEO of Sanofi, has taken quick steps to implement a plan announced on Feb. 6 to reduce the company's executive committee from 14 to 10 members. At the company’s Q4...
27.01.2020
- Sanofi has completed its acquisition of US biotech Synthorx as planned for $68 per share in cash. This follows expiration of the French pharma giant’s tender offer for all of the...
10.12.2019
- French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash...
